Evidence map›Paper›PMID 18772362›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2008

beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes.

Jyoti Sinha, Frank Chen, Tamir Miloh, Robert C Burns, Zhisheng Yu, Benjamin L Shneider

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.American journal of physiology. Gastrointestinal and liver physiology · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Bile Acid and Gut Microbiota in Irritable Bowel Syndrome.Journal of neurogastroenterology and motility · 2022
    Review
  11. Review
  12. Review
  13. The role of the retinoid receptor, RAR/RXR heterodimer, in liver physiology.Biochimica et biophysica acta. Molecular basis of disease · 2021
    Review
  14. Review
  15. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.Cellular and molecular gastroenterology and hepatology · 2020
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jyoti SinhaDepartment of Pediatrics, Mount Sinai School of Medicine, New York, NY, USA.
Frank Chen
Tamir Miloh
Robert C Burns
Zhisheng Yu
Benjamin L Shneider
Icahn School of Medicine at Mount Sinai · US

Funding

MOLECULAR REGULATION OF ILEAL/RENAL BILE ACID TRANSPORTR01DK054165 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHNEIDER, BENJAMIN L · 1997 to 2012
$2.8M
NIDDK NIH HHS DK 54165
6 · The paper itself

Abstract

beta-Klotho, a newly described membrane protein, regulates bile acid synthesis. Fibroblast growth factor-15 (FGF-15) and FGF receptor-4 (FGFR4) knockout mice share a similar phenotype with beta-Klotho-deficient mice. FGF-15 secretion by the intestine regulates hepatic bile acid biosynthesis. The effects of beta-Klotho and FGF-15 on the ileal apical sodium bile transporter (ASBT) are unknown. beta-Klotho siRNA treatment of the mouse colon cancer cell line, CT-26, and the human intrahepatic biliary epithelial cells (HIBEC) resulted in upregulation of endogenous ASBT expression that was associated with reduced expression of the farnesoid X receptor (FXR) and the short heterodimer partner (SHP). Silencing beta-Klotho activated the ASBT promoter in CT-26, Mz-ChA-1 (human cholangiocarcinoma), and HIBEC cells. Site-directed mutagenesis of liver receptor homolog-1 (mouse) or retinoic acid receptor/retinoid X receptor (RAR/RXR) (human) cis-elements attenuated the basal activity of the ASBT promoter and abrogated its response to beta-Klotho silencing. siSHP, siFXR, or dominant-negative FXR treatment also eliminated the beta-Klotho response. FGF-15 secretion into cell culture media by CT-26 cells was diminished after siFGF-15 or sibeta-Klotho treatment and enhanced by chenodeoxycholic acid. Exogenous FGF-19 repressed ASBT protein expression in mouse ileum, gallbladder, and in HIBEC and repressed ASBT promoter activity in Caco-2, HIBEC, and Mz-ChA-1 cells. Promoter repression was dependent on the expression of FGFR4. These results indicate that both beta-Klotho and FGF-15/19 repress ASBT in enterocytes and cholangiocytes. These novel signaling pathways need to be considered in analyzing bile acid homeostasis.

Indexed as

AnimalsCell LineDNA-Binding ProteinsEnterocytesFibroblast Growth FactorsGallbladderGene Expression RegulationHumansKlotho ProteinsMembrane ProteinsMiceMice, Inbred C57BLOrganic Anion Transporters, Sodium-DependentPromoter Regions, GeneticReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearDNA-Binding Proteinsfibroblast growth factor 15, mouseFibroblast Growth FactorsKlb protein, mouseKlotho ProteinsMembrane ProteinsOrganic Anion Transporters, Sodium-DependentReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and Nuclearsodium-bile acid cotransporterSymportersTranscription Factors

Identifiers

PMID18772362
PMCPMC2584833
OpenAlexW2132373502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.